Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:CPH TSE:GUD TSE:HLS BATS:WEED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHCipher PharmaceuticalsC$16.02+1.2%C$13.78C$10.61▼C$18.54C$406.81M0.55886328,263 shs26,847 shsGUDKnight TherapeuticsC$6.44C$6.23C$5.09▼C$6.55C$641.77M0.21924565,535 shs18,621 shsHLSHLS TherapeuticsC$5.45-1.4%C$5.05C$3.00▼C$5.61C$171.10M0.65083912,842 shs9,869 shsWEEDRoundhill Cannabis ETF$20.59+62.0%$15.91$8.79▼$34.14$4.41M0.9811,702 shs4,713 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHCipher Pharmaceuticals+1.20%+0.56%+24.67%+20.91%-13.12%GUDKnight Therapeutics0.00%-0.92%+2.38%+7.33%+14.59%HLSHLS Therapeutics-1.45%+1.68%+8.78%+10.77%+69.78%WEEDRoundhill Cannabis ETF+3.72%-13.57%+44.03%+103.25%-24.83%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPHCipher PharmaceuticalsC$16.02+1.2%C$13.78C$10.61▼C$18.54C$406.81M0.55886328,263 shs26,847 shsGUDKnight TherapeuticsC$6.44C$6.23C$5.09▼C$6.55C$641.77M0.21924565,535 shs18,621 shsHLSHLS TherapeuticsC$5.45-1.4%C$5.05C$3.00▼C$5.61C$171.10M0.65083912,842 shs9,869 shsWEEDRoundhill Cannabis ETF$20.59+62.0%$15.91$8.79▼$34.14$4.41M0.9811,702 shs4,713 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPHCipher Pharmaceuticals+1.20%+0.56%+24.67%+20.91%-13.12%GUDKnight Therapeutics0.00%-0.92%+2.38%+7.33%+14.59%HLSHLS Therapeutics-1.45%+1.68%+8.78%+10.77%+69.78%WEEDRoundhill Cannabis ETF+3.72%-13.57%+44.03%+103.25%-24.83%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPHCipher Pharmaceuticals 2.33HoldC$14.75-7.93% DownsideGUDKnight Therapeutics 3.33BuyC$7.1511.02% UpsideHLSHLS Therapeutics 2.00HoldC$5.00-8.26% DownsideWEEDRoundhill Cannabis ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HLS, GUD, WEED, and CPH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/21/2025HLSHLS TherapeuticsRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Moderate BuyC$5.00 ➝ C$6.00(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPHCipher PharmaceuticalsC$47.59M8.55C$4.54 per share3.53C$3.96 per share4.04GUDKnight TherapeuticsC$384.56M1.67C$1.67 per share3.85C$7.65 per share0.84HLSHLS TherapeuticsC$56.42M3.03C$0.36 per share15.22C$2.51 per share2.17WEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPHCipher PharmaceuticalsC$11.41MC$0.4634.83∞N/A59.92%17.93%7.90%N/AGUDKnight Therapeutics-C$30.73MN/AN/A∞N/A-8.81%-4.04%0.51%N/AHLSHLS Therapeutics-C$15.53M-C$0.48N/A∞N/A-38.70%-25.27%-2.89%N/AWEEDRoundhill Cannabis ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPHCipher PharmaceuticalsN/AN/AN/AN/AN/AGUDKnight TherapeuticsN/AN/AN/AN/AN/AHLSHLS TherapeuticsN/A4.30%N/AN/AN/AWEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPHCipher Pharmaceuticals41.222.002.67GUDKnight Therapeutics7.523.361.79HLSHLS Therapeutics86.501.561.01WEEDRoundhill Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPHCipher Pharmaceuticals3.24%GUDKnight Therapeutics15.93%HLSHLS Therapeutics0.42%WEEDRoundhill Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipCPHCipher Pharmaceuticals42.00%GUDKnight Therapeutics45.62%HLSHLS Therapeutics0.37%WEEDRoundhill Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPHCipher Pharmaceuticals525.39 millionN/ANot OptionableGUDKnight Therapeutics72599.65 millionN/ANot OptionableHLSHLS Therapeutics9131.39 millionN/ANot OptionableWEEDRoundhill Cannabis ETFN/A375,000N/ANot OptionableHLS, GUD, WEED, and CPH HeadlinesRecent News About These Companies5 Best-Performing Sector ETFs of AugustSeptember 3 at 7:31 AM | zacks.comRoundhill Cannabis ETF (BATS:WEED) Shares Up 74.6% - Time to Buy?September 3 at 2:34 AM | americanbankingnews.comTop-Performing ETF Areas of August That Are Up At Least 20%September 1, 2025 | zacks.comDisruptive Theme of the Week: Cannabis Staging a ComebackAugust 19, 2025 | etftrends.comECannabis ETFs Soar as Trump Mulls Over Marijuana ReclassificationAugust 12, 2025 | zacks.comDownbeaten cannabis stocks rally on report that Trump may lower pot's classification to a less-dangerous levelAugust 11, 2025 | marketwatch.com3 ETF Categories That Shined in July 2025August 7, 2025 | etftrends.comEBest-Performing ETF Areas of Last WeekJuly 15, 2025 | zacks.comTop & Flop ETFs of the First Half of 2025June 30, 2025 | zacks.com7 Best Marijuana Stocks and ETFs to Buy in 2025May 12, 2025 | money.usnews.com6 Best-Performing ETFs of Last WeekApril 21, 2025 | zacks.comRoundhill COIN WeeklyPay ETF (COIW)April 3, 2025 | uk.investing.comBest & Worst ETF Zones of Q1March 31, 2025 | zacks.comWhen (WEED) Moves Investors should ListenJanuary 19, 2025 | news.stocktradersdaily.comN(WEED) Pivots Trading Plans and Risk ControlsJanuary 9, 2025 | news.stocktradersdaily.comNTop & Flop ETFs of 2024December 31, 2024 | zacks.com(WEED) Long Term Investment AnalysisDecember 19, 2024 | news.stocktradersdaily.comN(WEED) Trading AdviceNovember 27, 2024 | news.stocktradersdaily.comN(WEED) Investment AnalysisNovember 17, 2024 | news.stocktradersdaily.comN(WEED) Investment ReportOctober 26, 2024 | news.stocktradersdaily.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHLS, GUD, WEED, and CPH Company DescriptionsCipher Pharmaceuticals TSE:CPHC$16.02 +0.19 (+1.20%) As of 09/5/2025 03:59 PM EasternCipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.Knight Therapeutics TSE:GUDC$6.44 0.00 (0.00%) As of 09/5/2025 04:00 PM EasternKnight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.HLS Therapeutics TSE:HLSC$5.45 -0.08 (-1.45%) As of 09/5/2025 03:19 PM EasternHLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.Roundhill Cannabis ETF BATS:WEED$20.59 +7.88 (+62.03%) Closing price 09/5/2025 03:57 PM EasternExtended Trading$20.19 -0.40 (-1.94%) As of 09/5/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Salesforce Stumbles, But Investors Eye a Major Comeback Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
